semaglutide manhattan Exclusive Semaglutide Weight Loss Program Manhattan

Ozempic (semaglutide) is a commonly prescribed drug used for managing glucose levels in people with Type 2 diabetes

Genetic predispositions inform personalized dosing strategies, reducing the trial-and-error period that often frustrates patients on traditional insurance-covered protocols

Keep in mind that no weight-loss drug is a substitute for a healthy lifestyle, and everyones needs are different

doi: 10.1016/S2213-8587(20)30431-9 69

Available for any patient

Why GLP-1 Receptor Agonists Can Alter Bowel Habits GLP-1 receptor activation delays gastric emptying and influences the enteric nervous system, causing variable bowel changes constipation, diarrhoea, or altered stool consistency depending on the individual and dose